Literature DB >> 8058324

An E2F dominant negative mutant blocks E1A induced cell cycle progression.

S F Dobrowolski1, D W Stacey, M L Harter, J T Stine, S W Hiebert.   

Abstract

E2F is a cellular transcription factor that is regulated during the cell cycle through interactions with the product of the retinoblastoma susceptibility gene (RB1) and the pRb-like p107 and p130 proteins. Analysis of mutations within both adenovirus E1A and pRb, which affected their ability to regulate cellular proliferation and alter E2F activity, suggested that E2F may play a role in cell cycle progression. Microinjection of a GST-E2F-1 fusion protein into quiescent Balb/c 3T3 cells induced DNA synthesis whereas co-injection of GST-E2F-1 and GST-E2F(95-191) protein, encoding only the DNA binding domain of E2F-1, blocked the induction of S-phase. While E1A likely targets multiple cellular pathways, co-injection of the GST-E2F(95-191) dominant inhibitory protein with 12S E1A protein blocked E1A-mediated induction of DNA synthesis, suggesting that the E2F-dependent pathway is dominant. Analysis of the interval required for microinjected quiescent cells to enter S-phase indicated that E2F-1 acted faster than either E1A or serum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058324

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase.

Authors:  Jingfeng Sha; Mrinal K Ghosh; Keman Zhang; Marian L Harter
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

2.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

3.  E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.

Authors:  J Nip; D K Strom; B E Fee; G Zambetti; J L Cleveland; S W Hiebert
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 4.  E2F transcription factor action, regulation and possible role in human cancer.

Authors:  T L Sladek
Journal:  Cell Prolif       Date:  1997 Mar-Apr       Impact factor: 6.831

5.  Gap 1 phase length and mouse embryonic stem cell self-renewal.

Authors:  Victor C Li; Andrea Ballabeni; Marc W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

6.  Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.

Authors:  A Mal; A Piotrkowski; M L Harter
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  Identification of E2F target genes that are rate limiting for dE2F1-dependent cell proliferation.

Authors:  Anabel Herr; Michelle Longworth; Jun-Yuan Ji; Michael Korenjak; David M Macalpine; Nicholas J Dyson
Journal:  Dev Dyn       Date:  2012-09-17       Impact factor: 3.780

8.  Functional antagonism between E2F family members.

Authors:  M V Frolov; D S Huen; O Stevaux; D Dimova; K Balczarek-Strang; M Elsdon; N J Dyson
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

9.  Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.

Authors:  C L Wu; M Classon; N Dyson; E Harlow
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

10.  E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis.

Authors:  S W Hiebert; G Packham; D K Strom; R Haffner; M Oren; G Zambetti; J L Cleveland
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.